Purchase Agreements
Pharmaceuticals
Pharmaceuticals (1,497) | Purchase Agreements (40,366)
- 4Front Ventures Corp. (5 contracts)
- 60 DEGREES PHARMACEUTICALS, INC. (19)
- Acacia Diversified Holdings, Inc. (6)
- Accelerated Pharma, Inc. (11)
- ACELRX PHARMACEUTICALS INC (7)
- Acer Therapeutics Inc. (10)
- Aclaris Therapeutics, Inc. (4)
- Acreage Holdings, Inc. (1)
- ACURA PHARMACEUTICALS, INC (1)
- Adamis Pharmaceuticals Corp (15)
- ADIAL PHARMACEUTICALS, INC. (10)
- Aegerion Pharmaceuticals, Inc. (1)
- AEOLUS PHARMACEUTICALS, INC. (8)
- Aerpio Pharmaceuticals, Inc. (3)
- AGILE THERAPEUTICS INC (5)
- Akers Biosciences, Inc. (11)
- AKESIS PHARMACEUTICALS, INC. (1)
- Akorn (6)
- Alexza Pharmaceuticals Inc. (2)
- ALIMERA SCIENCES INC (9)
- Allergan, plc (5)
- ALSERES PHARMACEUTICALS INC (14)
- Altus Pharmaceuticals Inc. (4)
- Amag Pharmaceuticals (3)
- Amneal Pharmaceuticals, Inc. (4)
- Amphastar Pharma (1)
- Ampio Pharmaceuticals, Inc. (10)
- Anebulo Pharmaceuticals, Inc. (1)
- ANGIOTECH PHARMACEUTICALS INC (1)
- ANI Pharma Inc (9)
- Anthera Pharmaceuticals Inc (5)
- APP Pharmaceuticals, Inc. (2)
- Applied BioSciences Corp. (2)
- APRICUS BIOSCIENCES, INC. (26)
- Aquestive Therapeutics, Inc. (5)
- ARADIGM CORP (7)
- Aralez Pharmaceuticals Inc. (22)
- Arog Pharmaceuticals, Inc. (1)
- ARTELO BIOSCIENCES, INC. (2)
- Artemis Therapeutics, Inc. (6)
- Assertio Holdings, Inc. (3)
- Assertio Therapeutics, Inc (10)
- Astex Pharmaceuticals, Inc (4)
- AVADEL PHARMACEUTICALS PLC (5)
- AVALON PHARMACEUTICALS INC (4)
- AVANIR PHARMACEUTICALS, INC. (1)
- AVENUE THERAPEUTICS, INC. (2)
- AXIM BIOTECHNOLOGIES, INC. (5)
- Axsome Therapeutics, Inc. (2)
- AYTU BIOSCIENCE, INC (14)
- BARR PHARMACEUTICALS INC (2)
- Barrel Energy Inc. (1)
- Baudax Bio, Inc. (10)
- Bausch Health Companies Inc. (6)
- Bespoke Extracts, Inc. (17)
- Big Rock Partners Acquisition Corp. (7)
- BIODELIVERY SCIENCES INTERNATIONAL INC (11)
- Biofrontera Inc. (3)
- BioPharmX Corp (10)
- Biostar Pharmaceuticals, Inc. (2)
- Blue Water Acquisition Corp. (2)
- BODY & MIND INC. (6)
- Boston Therapeutics, Inc. (12)
- BRADLEY PHARMACEUTICALS INC (1)
- Bright Green Corp (2)
- Bristol-Myers Squibb (1)
- CADENCE PHARMACEUTICALS INC (1)
- CALLISTO PHARMACEUTICALS INC (3)
- Canbiola, Inc. (18)
- Cancer Prevention Pharmaceuticals, Inc. (1)
- Cannabics Pharmaceuticals Inc. (4)
- CANNAPHARMARX, INC. (10)
- CANNAPOWDER, INC. (1)
- Cantabio Pharmaceuticals Inc. (4)
- Cara Therapeutics, Inc. (1)
- CARDAX, INC. (5)
- CASSAVA SCIENCES INC (4)
- Catalent Inc (1)
- Celator Pharmaceuticals Inc (1)
- CELGENE CORP (1)
- Cerecor Inc. (11)
- CHINA PHARMA HOLDINGS, INC. (2)
- Cingulate Inc. (2)
- Citius Pharmaceuticals, Inc. (9)
- Clearside Biomedical, Inc. (2)
- CLS Holdings USA, Inc. (16)
- CNS Pharmaceuticals, Inc. (4)
- Cocrystal Pharma, Inc. (22)
- COGNITION THERAPEUTICS INC (1)
- COLLAGENEX PHARMACEUTICALS INC (1)
- COLLEGIUM PHARMACEUTICAL, INC (1)
- Context Therapeutics Inc. (2)
- ContraVir Pharmaceuticals, Inc. (7)
- Corcept Therapeutics Incorporated (3)
- CorMedix Inc. (8)
- COSMO VENTURES INC (2)
- Cronos Group Inc. (1)
- CUBIST PHARMACEUTICALS INC (1)
- CUMBERLAND PHARMACEUTICALS INC (3)
- Cure Pharmaceutical Holding Corp. (3)
- Dermata Therapeutics, Inc. (4)
- DURECT CORP (4)
- DUSA PHARMACEUTICALS INC (1)
- Egalet Corp (2)
- ELITE PHARMACEUTICALS INC (12)
- Eloxx Pharmaceuticals, Inc. (5)
- ENCYSIVE PHARMACEUTICALS INC (2)
- Endexx Corp (2)
- Endo International plc (4)
- Endo Pharmaceuticals Solutions Inc. (3)
- EPIX Pharmaceuticals, Inc. (2)
- Eton Pharmaceuticals, Inc. (7)
- Evofem Biosciences, Inc. (19)
- Evoke Pharma Inc (5)
- Exactus, Inc. (5)
- EYEGATE PHARMACEUTICALS INC (11)
- EYENOVIA, INC. (3)
- EyePoint Pharmaceuticals, Inc. (3)
- Foamix Pharmaceuticals Ltd. (1)
- FRONTIER OILFIELD SERVICES INC (1)
- Fulcrum Therapeutics, Inc. (1)
- Furiex Pharmaceuticals, Inc. (1)
- Gala Pharmaceutical Inc. (1)
- GB SCIENCES INC (8)
- GREEN HYGIENICS HOLDINGS INC. (6)
- GridIron BioNutrients, Inc. (7)
- GUILFORD PHARMACEUTICALS INC (1)
- HARROW HEALTH, INC. (17)
- Haymaker Acquisition Corp. III (3)
- Horizon Pharma plc (4)
- Hoth Therapeutics, Inc. (8)
- IMAGING3 INC (1)
- IMARA Inc. (2)
- INNOVATE BIOPHARMACEUTICALS, INC. (9)
- Innoviva, Inc. (2)
- IntelGenx Technologies Corp. (10)
- Intersect ENT, Inc. (1)
- ISTA PHARMACEUTICALS INC (4)
- Item 9 Labs Corp. (5)
- Iterum Therapeutics plc (10)
- Jaguar Health, Inc. (27)
- Jazz Pharmaceuticals plc (5)
- Jiangbo Pharmaceuticals, Inc. (2)
- Journey Medical Corp (6)
- JUNIPER PHARMACEUTICALS INC (7)
- Jushi Holdings Inc. (1)
- Kala Pharmaceuticals, Inc. (2)
- Kannalife Inc (5)
- Kedem Pharmaceuticals Inc. (1)
- KEMPHARM, INC (5)
- KING PHARMACEUTICALS INC (3)
- KOS PHARMACEUTICALS INC (1)
- Landos Biopharma, Inc. (1)
- Lannett Company, Inc. (1)
- Lev Pharmaceuticals Inc (3)
- Level Brands, Inc. (2)
- Lexaria Bioscience Corp. (11)
- Lipocine Inc. (3)
- Longboard Pharmaceuticals, Inc. (1)
- Lowell Farms Inc. (1)
- Luckwel Pharmaceuticals Inc. (1)
- Lyra Therapeutics, Inc. (1)
- Mallinckrodt (5)
- Marijuana Co of America, Inc. (2)
- MARINUS PHARMACEUTICALS INC (2)
- MedGen, Inc. (1)
- Medicine Man Technologies, Inc. (40)
- MedMen Enterprises, Inc. (3)
- Melt Pharmaceuticals, Inc. (1)
- MEMORY PHARMACEUTICALS CORP (1)
- Menlo Therapeutics Inc. (4)
- MICROCHANNEL TECHNOLOGIES CORP (5)
- MiddleBrook Pharmaceuticals, Inc. (7)
- Milestone Pharmaceuticals Inc. (3)
- MJ Holdings, Inc. (10)
- Molecular Insight Pharmaceuticals, Inc. (2)
- Mylan N.V. (2)
- MYnd Analytics, Inc. (5)
- Nabriva Therapeutics plc (5)
- NEKTAR THERAPEUTICS (4)
- Neuralstem, Inc. (12)
- NEW RIVER PHARMACEUTICALS INC (1)
- NewBridge Global Ventures, Inc. (10)
- NEXIEN BIOPHARMA, INC. (1)
- Notis Global, Inc. (28)
- NovaBay Pharmaceuticals, Inc. (15)
- Novan, Inc. (6)
- NOVEN PHARMACEUTICALS INC (1)
- NPS PHARMACEUTICALS INC (6)
- NURX PHARMACEUTICALS, INC. (1)
- OMEROS CORP (2)
- OncoMed Pharmaceuticals Inc (1)
- Onconova Therapeutics, Inc. (12)
- One World Pharma, Inc. (7)
- OPIANT PHARMACEUTICALS, INC. (2)
- ORAMED PHARMACEUTICALS INC. (11)
- OSCIENT PHARMACEUTICALS CORP (2)
- Osmotica Pharmaceuticals plc (1)
- Panacea Acquisition Corp (6)
- PANACOS PHARMACEUTICALS, INC. (1)
- Paratek Pharmaceuticals, Inc. (2)
- PaxMedica, Inc. (2)
- PENWEST PHARMACEUTICALS CO (1)
- PetLife Pharmaceuticals, Inc. (2)
- Petros Pharmaceuticals, Inc. (3)
- Pharmagreen Biotech Inc. (4)
- PHARMOS CORP (2)
- Phibro Animal Health Corporation (4)
- Planet 13 Holdings Inc. (2)
- PLAYERS NETWORK (22)
- PLx Pharma Inc. (13)
- POLYDEX PHARMACEUTICALS LTD (1)
- PONIARD PHARMACEUTICALS, INC. (2)
- PRAECIS PHARMACEUTICALS INC (1)
- Prestige Brands Holdings Inc (4)
- PRESTWICK PHARMACEUTICALS INC (1)
- Processa Pharmaceuticals, Inc. (7)
- ProPhase Labs, Inc. (3)
- PROVECTUS BIOPHARMACEUTICALS, INC. (3)
- Provention Bio, Inc. (7)
- Pulmatrix, Inc. (11)
- QUANTA INC (4)
- QUESTCOR PHARMACEUTICALS INC (3)
- Quoin Pharmaceuticals, Ltd. (2)
- RADIENT PHARMACEUTICALS Corp (1)
- Recro Pharma, Inc. (6)
- Reliant Pharmaceuticals, Inc. (1)
- RELMADA THERAPEUTICS, INC. (5)
- RespireRx Pharmaceuticals Inc. (24)
- ROCK CREEK PHARMACEUTICALS, INC. (4)
- Roivant Sciences Ltd. (4)
- Royalty Pharma plc (5)
- Sagent Pharmaceuticals, Inc. (3)
- SALIX PHARMACEUTICALS LTD (2)
- Satsuma Pharmaceuticals, Inc. (1)
- SAVIENT PHARMACEUTICALS INC (1)
- SCICLONE PHARMACEUTICALS INC (2)
- Scopus BioPharma Inc. (3)
- SCYNEXIS INC (1)
- SenesTech, Inc. (9)
- SIGA TECHNOLOGIES INC (2)
- Sonoma Pharmaceuticals, Inc. (16)
- Stem Holdings, Inc. (1)
- Sucampo Pharmaceuticals, Inc. (3)
- Sunset Island Group (2)
- SUNWIN STEVIA INTERNATIONAL, INC. (1)
- Supernus Pharmaceuticals, Inc. (8)
- SYNERGY PHARMACEUTICALS, INC. (12)
- Synovics Pharmaceuticals (1)
- TAPESTRY PHARMACEUTICALS, INC (1)
- Target Group Inc. (10)
- Targeted Medical Pharma, Inc. (4)
- TAURIGA SCIENCES, INC. (40)
- Tenzing Acquisition Corp. (6)
- Terra Tech Corp. (33)
- TerrAscend Corp. (1)
- TETRALOGIC PHARMACEUTICALS CORP (2)
- TETRAPHASE PHARMACEUTICALS INC (3)
- Textmunication Holdings, Inc. (11)
- TFF Pharmaceuticals, Inc. (3)
- The Medicines Company (1)
- TherapeuticsMD, Inc. (1)
- Theravance Biopharma, Inc. (2)
- TITAN PHARMACEUTICALS INC (10)
- Tribute Pharmaceuticals Canada Inc. (7)
- Tricida, Inc. (1)
- Upjohn Inc (1)
- Urigen Pharmaceuticals, Inc. (3)
- Urovant Sciences Ltd. (1)
- VALEANT PHARMACEUTICALS INTERNATIONAL (1)
- Valera Pharmaceuticals Inc (1)
- Vallon Pharmaceuticals, Inc. (4)
- VASO ACTIVE PHARMACEUTICALS INC (1)
- Ventyx Biosciences, Inc. (1)
- VIA Pharmaceuticals, Inc. (3)
- Vitality Biopharma, Inc. (16)
- VIVUS INC (7)
- WEED, INC. (3)
- XANODYNE PHARMACEUTICALS INC (1)
- Xeris Biopharma Holdings, Inc. (1)
- XERIS PHARMACEUTICALS INC (1)
- ZOGENIX, INC. (6)
- Zomedica Pharmaceuticals Corp. (6)
- Zynerba Pharmaceuticals, Inc. (1)
- Amendment No. 1 to Asset Purchase Agreement dated May 26, 2023 by and among PLx Pharma Inc., PLx Opco Inc. and PLx Acquisition Company, LLC (PLx Pharma Inc., Filed With SEC on May 26, 2023)
- Form of Securities Purchase Agreement, dated May 22, 2023, by and between Agile Therapeutics, Inc. and certain purchasers (AGILE THERAPEUTICS INC, Filed With SEC on May 25, 2023)
- Securities Purchase Agreement dated May 21, 2023, by and between the Company and the purchasers thereto (Bright Green Corp, Filed With SEC on May 24, 2023)
- Form of Securities Purchase Agreement, dated May 23, 2023, by and between the Company and the Purchasers (Dermata Therapeutics, Inc., Filed With SEC on May 24, 2023)
- Form of Amendment No. 1 to Securities Purchase Agreement, by and between Seelos Therapeutics, Inc. and each purchaser identified on the signature pages thereto, dated May 19, 2023 (APRICUS BIOSCIENCES, INC., Filed With SEC on May 19, 2023)
- Form of Securities Purchase Agreement, by and between Agile Therapeutics, Inc. and the purchasers signatory thereto (AGILE THERAPEUTICS INC, Filed With SEC on May 19, 2023)
- Securities Purchase Agreement dated as of May 8, 2023, by and between Registrant and Cyberbahn Federal Solutions, LLC (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on May 19, 2023)
- Securities Purchase Agreement dated as of May 8, 2023, by and between Registrant and Ariana Bakery Inc (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on May 19, 2023)
- Securities Purchase Agreement dated as of May 8, 2023, by and between Registrant and Steel Anderson (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on May 19, 2023)
- Securities Purchase Agreement dated as of May 8, 2023, by and between Registrant and Bixi Gao & Ling Ling Wang (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on May 19, 2023)
- Securities Purchase Agreement dated March 14, 2023 (Adamis Pharmaceuticals Corp, Filed With SEC on May 15, 2023)
- Asset Purchase Agreement, dated January 25, 2023, by and among Medicine Man Technologies, Inc., Smoke Holdco, LLC, Cannabis Care Wellness Centers, LLC, Green Medicals Wellness... (Medicine Man Technologies, Inc., Filed With SEC on May 11, 2023)
- Form of Securities Purchase Agreement (Jaguar Health, Inc., Filed With SEC on May 9, 2023)
- Form of Securities Purchase Agreement, dated May 3, 2023, by and between Citius Pharmaceuticals, Inc. and the purchasers signatory thereto (Citius Pharmaceuticals, Inc., Filed With SEC on May 8, 2023)
- Securities Purchase Agreement dated as of May 24, 2022, by and between Registrant and Walleye Opportunities Master Fund Ltd (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 28, 2023)
- Securities Purchase Agreement dated as of May 24, 2022, by and between Registrant and Cavalry Investment Fund, LP (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 28, 2023)
- Securities Purchase Agreement dated as of May 24, 2022, by and between Registrant and Bigger Capital Fund, LP (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 28, 2023)
- Securities Purchase Agreement dated as of May 19, 2022, by and between Registrant and Mountjoy Trust (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 28, 2023)
- Securities Purchase Agreement dated as of May 19, 2022, by and between the Registrant and Geoffrey Dow (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 28, 2023)
- Form of Securities Purchase Agreement (Lexaria Bioscience Corp., Filed With SEC on April 28, 2023)
- Form of Securities Purchase Agreement (NovaBay Pharmaceuticals, Inc., Filed With SEC on April 27, 2023)
- Asset Purchase Agreement, dated April 21, 2023, by and among Medicine Man Technologies, Inc., Evergreen Holdco, LLC, Sucellus, LLC, Brook Laskey, as Representative, and the... (Medicine Man Technologies, Inc., Filed With SEC on April 26, 2023)
- Form of Securities Purchase Agreement, by and between Baudax Bio, Inc. and the purchasers party thereto (Baudax Bio, Inc., Filed With SEC on April 26, 2023)
- Purchase Agreement, dated April 24, 2023, by and between the Company and Lincoln Park Capital Fund, LLC (Cingulate Inc., Filed With SEC on April 25, 2023)
- Asset Purchase Agreement, dated April 13, 2023, by and among Medicine Man Technologies, Inc., Double Brow, LLC, Standing Akimbo LLC, Spencer Kirson, and John Murphy (Medicine Man Technologies, Inc., Filed With SEC on April 19, 2023)
- Walleye Securities Purchase Agreement (Canbiola, Inc., Filed With SEC on April 17, 2023)
- Form of Securities Purchase Agreement dated April 11, 2023, between the Company and the Purchasers (Vitality Biopharma, Inc., Filed With SEC on April 13, 2023)
- Asset Purchase Agreement, dated April 12, 2023, by and among PLx Pharma Inc., PLx Opco Inc. and PLx Acquisition Company, LLC (PLx Pharma Inc., Filed With SEC on April 12, 2023)
- Form of Securities Purchase Agreement (SenesTech, Inc., Filed With SEC on April 12, 2023)
- Securities Purchase Agreement dated April 4, 2023 (Cocrystal Pharma, Inc., Filed With SEC on April 10, 2023)
- Form of Securities Purchase Agreement (Evofem Biosciences, Inc., Filed With SEC on April 10, 2023)
- Form of Securities Purchase Agreement (Neuralstem, Inc., Filed With SEC on April 5, 2023)
- Securities Purchase Agreement dated as of May 19, 2022, by and between the Registrant and Geoffrey Dow (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 3, 2023)
- Securities Purchase Agreement dated as of May 24, 2022, by and between Registrant and Walleye Opportunities Master Fund Ltd (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 3, 2023)
- Securities Purchase Agreement dated as of May 19, 2022, by and between Registrant and Mountjoy Trust (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 3, 2023)
- Securities Purchase Agreement dated as of May 24, 2022, by and between Registrant and Bigger Capital Fund, LP (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 3, 2023)
- Securities Purchase Agreement dated as of May 24, 2022, by and between Registrant and Cavalry Investment Fund, LP (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 3, 2023)
- Royalty Purchase Agreement, dated as of March 27, 2023, by and among the Company and RTW (Milestone Pharmaceuticals Inc., Filed With SEC on March 31, 2023)
- Purchase and Sale Agreement, dated March 29, 2023, between Avadel CNS Pharmaceuticals, LLC, the Company, Flamel Ireland Ltd., and RTW Royalty II DAC (AVADEL PHARMACEUTICALS PLC, Filed With SEC on March 30, 2023)
- First Amendment to Asset Purchase Agreement, dated December 15, 2022, by and among by and among Medicine Man Technologies, Inc., Double Brow, LLC, Lightshade Labs LLC, Thomas Van... (Medicine Man Technologies, Inc., Filed With SEC on March 29, 2023)